{"id":"NCT02648204","sponsor":"Novo Nordisk A/S","briefTitle":"Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.","officialTitle":"Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-01-06","primaryCompletion":"2017-04-10","completion":"2017-05-19","firstPosted":"2016-01-06","resultsPosted":"2018-05-08","lastUpdate":"2019-10-15"},"enrollment":1201,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"semaglutide","otherNames":[]},{"type":"DRUG","name":"Dulaglutide","otherNames":[]}],"arms":[{"label":"Semaglutide 0.5 mg/Week","type":"EXPERIMENTAL"},{"label":"Semaglutide 1.0 mg/Week","type":"EXPERIMENTAL"},{"label":"Dulaglutide 0.75 mg/Week","type":"ACTIVE_COMPARATOR"},{"label":"Dulaglutide 1.5 mg/Week","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of semaglutide versus dulaglutide as add-on to metformin in subjects with type 2 diabetes.","primaryOutcome":{"measure":"Change in HbA1c","timeFrame":"Week 0, week 40","effectByArm":[{"arm":"Semaglutide 0.5 mg","deltaMin":-1.51,"sd":0.06},{"arm":"Semaglutide 1.0 mg","deltaMin":-1.78,"sd":0.06},{"arm":"Dulaglutide 0.75 mg","deltaMin":-1.11,"sd":0.05},{"arm":"Dulaglutide 1.5 mg","deltaMin":-1.37,"sd":0.06}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG003","p":"<0.0001"},{"comp":"OG001 vs OG003","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":209,"countries":["United States","Bulgaria","Croatia","Finland","Germany","Greece","Hong Kong","India","Ireland","Latvia","Lithuania","Portugal","Puerto Rico","Romania","Slovakia","Spain","United Kingdom"]},"refs":{"pmids":["30865526","30927241","31168765","29397376","29246950","29764222","29557057","30615985","30362224","38777128","33199417","31769496","31215727"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":301},"commonTop":["Nausea","Diarrhoea","Vomiting","Decreased appetite","Headache"]}}